Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC — Stella

Home/Bladder Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Bladder Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The first affiliated hospital of Nanjing Medical University, Nanjing, Jiangsu

Key details

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

The Second Affiliated Hospital of Kunming Medical University, Tianjin Medical University Second Hospital

Enrollment target

~200 participants

Started

July 2021

Primary completion

June 2027

Age range

18 Years – 75 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.